Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-01-20
DOI
https://doi.org/10.1111/dom.70507
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?

Leonidas H. Duntas, Stergios A. Polyzos, Giovanni Targher, Jannis Kountouras
Diabetes Obesity and Metabolism
Liver Disease Diagnosis and Treatment
article

Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?

Leonidas H. Duntas, Stergios A. Polyzos, Giovanni Targher, Jannis Kountouras
article en

Abstract

No abstract available for this paper.
Diabetes Obesity and MetabolismVol. 28(4)
University of Verona (IT), National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), Ospedale Sacro Cuore Don Calabria (IT)
Good health and well-being
Openalex Percentile: Top 83%
Liver Disease Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.